ijms-logo

Journal Browser

Journal Browser

Recent Research on Cardiac Troponins

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (28 February 2025) | Viewed by 350

Special Issue Editors


E-Mail Website
Guest Editor
Institute of Clinical Physiology, CNR, Via Moruzzi 1, 56124 Pisa, Italy
Interests: molecular mechanisms of cardiovascular disease; cardiac miRNA; cardiac troponin

Special Issue Information

Dear Colleagues,

The cardiac troponin complex (cTn) is a regulatory component of sarcomere, consisting of three subunits: cardiac troponin C (cTnC), which confers Ca2+ sensitivity to muscle; cTnI, which inhibits the interaction of myosin cross-bridges with thin filaments during diastole; and cTnT, which has multiple roles in sarcomere, such as promoting the link between the cTnI-cTnC complex and tropomyosin within thin filaments and influencing the Ca2+ sensitivity of cTn and forcing development during contraction. Conditions that interfere with interactions within cTn and/or other thin filament proteins can be key factors in the regulation of cardiac contractions. These conditions include alterations in myofilament Ca2+ sensitivity, direct changes in cTn function, and/or triggering downstream events that lead to adverse cardiac remodeling and impairment of heart function.

Moreover, circulating cTnT and cTnI increase following cardiac tissue necrosis, and they are consolidated biomarkers of acute myocardial infarction. However, the use of high-sensitivity (hs) immunoassay tests for cTnT and cTnI has made it possible to identify a multitude of other clinical conditions associated with increased circulating levels of cTns. cTns can also be measured in the peripheral circulation of healthy subjects or athletes, suggesting that different mechanisms are involved in the release of cTns in the blood independently of cardiac cell necrosis.

This Special Issue aims to evaluate the mechanisms of cTns regulation that can adversely affect the delicate balance among the components of the complex, thereby promoting contractile dysfunction, together with the molecular/cellular processes involved in cTns release in blood and the exploitation of cTnI and cTnT as biomarkers of cardiac adverse events.

Dr. Chiara Caselli
Dr. Rosetta Ragusa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiac troponin
  • gene mutations
  • post-translational modifications
  • therapy
  • high-sensitivity (hs) immunoassays
  • mechanisms of release
  • biomarkers
  • cardiovascular disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

25 pages, 1484 KiB  
Review
Recent Evidences of Epigenetic Alterations in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review
by Rosetta Ragusa, Pasquale Bufano, Alessandro Tognetti, Marco Laurino and Chiara Caselli
Int. J. Mol. Sci. 2025, 26(6), 2571; https://doi.org/10.3390/ijms26062571 - 13 Mar 2025
Viewed by 100
Abstract
Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory condition characterized by progressive airflow limitation, which may be caused by genetic and environmental factors. Furthermore, epigenetic mechanisms could provide valuable insights into the complex interactions between environment and genes and subsequent development of [...] Read more.
Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory condition characterized by progressive airflow limitation, which may be caused by genetic and environmental factors. Furthermore, epigenetic mechanisms could provide valuable insights into the complex interactions between environment and genes and subsequent development of the disease. The aim of this study is to provide a systematic review of the latest knowledge on epigenetic modifications that characterize COPD, summarizing epigenetic factors that could serve as potential novel biomarkers and therapeutic targets for the treatment of COPD patients. We queried the PubMed and Scopus electronic databases with specific keywords, in May 2024, according to the PRISMA guidelines, and articles were included if they met all the inclusion criteria and survived a quality assessment. We identified 5414 publications in our systematic search. Among them, only 51 articles met the criteria of COPD-associated epigenetic modifications in human patients compared to the control group. Eight studies described DNA methylation, one study histone modifications, and forty-two studies non-coding RNAs. Apoptosis and inflammatory pathways have been found to be the main mechanisms regulated by epigenetic elements in COPD patients. In addition, non-coding RNAs may be useful as biomarkers or therapeutic targets of pulmonary disease. Future studies will be needed to confirm the role of epigenetic elements associated with COPD. Full article
(This article belongs to the Special Issue Recent Research on Cardiac Troponins)
Show Figures

Figure 1

Back to TopTop